| scholarly article | Q13442814 |
| P2093 | author name string | K G Reymann | |
| A Hahn | |||
| G Gross | |||
| H Schoemaker | |||
| A Möller | |||
| V Nimmrich | |||
| K Wicke | |||
| M Strassburger | |||
| U H Schöder | |||
| P2860 | cites work | Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo | Q28131779 |
| Benzoylalanine-derived ketoamides carrying vinylbenzyl amino residues: discovery of potent water-soluble calpain inhibitors with oral bioavailability | Q28207370 | ||
| The role of autophagy in age-related neurodegeneration | Q28261965 | ||
| The roles of intracellular protein-degradation pathways in neurodegeneration | Q28269322 | ||
| Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease | Q28269894 | ||
| Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway | Q28854318 | ||
| A specific amyloid-beta protein assembly in the brain impairs memory | Q28854597 | ||
| Neuroprotective properties of memantine in differentin vitroandin vivomodels of excitotoxicity | Q29029398 | ||
| A simple method for organotypic cultures of nervous tissue | Q29614375 | ||
| Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function | Q29614851 | ||
| Amyloid beta oligomers (A beta(1-42) globulomer) suppress spontaneous synaptic activity by inhibition of P/Q-type calcium currents. | Q30179416 | ||
| Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. | Q33195171 | ||
| Excitatory amino acids as a final common pathway for neurologic disorders. | Q34321926 | ||
| Progressive incorporation of propidium iodide in cultured mouse neurons correlates with declining electrophysiological status: a fluorescence scale of membrane integrity | Q34452978 | ||
| Calpain inhibitors, but not caspase inhibitors, prevent actin proteolysis and DNA fragmentation during apoptosis | Q34457040 | ||
| Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain | Q34714755 | ||
| The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease | Q37054679 | ||
| Beta-amyloid disrupted synaptic vesicle endocytosis in cultured hippocampal neurons. | Q41437626 | ||
| Beta-amyloid-induced dynamin 1 depletion in hippocampal neurons. A potential mechanism for early cognitive decline in Alzheimer disease. | Q42274064 | ||
| Inhibition of Calpain Prevents N-Methyl-D-aspartate-Induced Degeneration of the Nucleus Basalis and Associated Behavioral Dysfunction | Q42440226 | ||
| beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis | Q42492837 | ||
| The novel calpain inhibitor A-705253 potently inhibits oligomeric beta-amyloid-induced dynamin 1 and tau cleavage in hippocampal neurons. | Q43213857 | ||
| Stage-dependent and sector-specific neuronal loss in hippocampus during Alzheimer's disease | Q43924252 | ||
| Calpain mediates excitotoxic DNA fragmentation via mitochondrial pathways in adult brains: evidence from calpastatin mutant mice. | Q45251288 | ||
| Calpain and N-methyl-d-aspartate (NMDA)-induced excitotoxicity in rat retinas | Q46476462 | ||
| Calpain-mediated mGluR1alpha truncation: a key step in excitotoxicity | Q46769581 | ||
| Calpain-cleaved collapsin response mediator protein-3 induces neuronal death after glutamate toxicity and cerebral ischemia. | Q46958346 | ||
| Cdk5 is a key factor in tau aggregation and tangle formation in vivo | Q48300530 | ||
| beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. | Q48463841 | ||
| Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. | Q48963534 | ||
| Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. | Q48970270 | ||
| Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. | Q50455488 | ||
| Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. | Q53245545 | ||
| Neuronal loss in primary long-term cortical culture involves neurodegeneration-like cell death via calpain and p35 processing, but not developmental apoptosis or aging. | Q53576708 | ||
| Differences in the pattern of hippocampal neuronal loss in normal ageing and Alzheimer's disease | Q57132920 | ||
| Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as | Q79851539 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell death | Q2383867 |
| P304 | page(s) | 1523-31 | |
| P577 | publication date | 2010-04-01 | |
| P1433 | published in | British Journal of Pharmacology | Q919631 |
| P1476 | title | Inhibition of calpain prevents NMDA-induced cell death and beta-amyloid-induced synaptic dysfunction in hippocampal slice cultures | |
| P478 | volume | 159 |
| Q38014513 | Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections |
| Q38099671 | Amyloid β, glutamate, excitotoxicity in Alzheimer's disease: are we on the right track? |
| Q39004902 | Calpain research for drug discovery: challenges and potential |
| Q38026045 | Consequences of inhibiting amyloid precursor protein processing enzymes on synaptic function and plasticity |
| Q36881509 | Differential roles for caspase-mediated and calpain-mediated cell death in 1- and 3-week-old rat cortical cultures |
| Q64998890 | Involvement of calpain in the neuropathogenesis of Alzheimer's disease. |
| Q47120381 | Neuroprotective astrocyte-derived insulin/insulin-like growth factor 1 stimulates endocytic processing and extracellular release of neuron-bound Aβ oligomers. |
| Q34493905 | Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture |
| Q44516795 | Tat-collapsin response mediator protein 2 (CRMP2) increases the survival of neurons after NMDA excitotoxity by reducing the cleavage of CRMP2. |
| Q36208482 | Temporal dependence of cysteine protease activation following excitotoxic hippocampal injury |
| Q37845675 | The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease |
Search more.